Get the Weekly Intelligence Brief — top committee picks every Sunday.

ACAD vs SNN

ACADIA Pharmaceuticals Inc. vs Smith & Nephew plc — AI-powered side-by-side comparison
ACAD
ACADIA Pharmaceuticals Inc.
69
Buy
VS
SNN
Smith & Nephew plc
59
Watch
MetricACADSNN
AI Score 69 59
Price $29.41 $30.05
P/E Ratio 13.07× 19.70×
ROE 31.9% 11.8%
Revenue Growth YoY
Gross Margin 91.1% 68.2%
Debt / Equity 0.06× 0.73×
Dividend Yield 0.0% 2.6%
RSI (14) 78.4 40.7
Beta 0.845 0.688
Expected Upside

AI Committee View

Current Innellis committee reasoning for ACAD versus SNN.
ACAD leads by 10 points.

ACAD scores 69/100 (Buy) versus SNN at 59/100 (Watch).

ACAD Committee View
83% agreement
6 analysts

The primary driver is revenue growing 47.0% yoy -- genuine top-line momentum. The main limiting factor is bollinger bandwidth of 24.3% signals elevated volatility. The committee is constructive but not yet at full conviction.

Bull Case
  • P/E of 13.2 is inexpensive for the broad market — Value
  • ROE of 32.4% shows genuine earnings power backing the valuation — Value
  • Revenue growing 47.0% YoY -- genuine top-line momentum — Growth
Bear Case
  • RSI at 78 is in overbought territory — Technical
  • Weekly RSI at 80 -- overbought on the larger timeframe too — Technical
  • Bollinger bandwidth of 24.3% signals elevated volatility — Risk
SNN Committee View
40% agreement
5 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Technical Analyst remains cautious — price structure making lower highs and lower lows. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Dividend yield of 2.7% pays you to wait — Value
  • EPS growing 52.3% YoY — Growth
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
  • Price structure making lower highs and lower lows — Technical
  • MACD histogram negative -- bearish momentum — Technical
  • Trend and market structure agree -- coherent bearish picture — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ACAD Full Analysis SNN Full Analysis